Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit

Drug Metabolism and Disposition

Volumn 27, Issue 1, 1999, Pages 81-85

  Pichette, Vincent ^b   Geadah, David ^b   Du Souich, Patrick ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; FUROSEMIDE; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOTRANSFORMATION; CONTROLLED STUDY; DIURESIS; DRUG BINDING; DRUG CLEARANCE; DRUG DISTRIBUTION; HYPOALBUMINEMIA; KIDNEY METABOLISM; KIDNEY TUBULE EXCRETION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RABBIT; SODIUM EXCRETION; URINARY EXCRETION;

ANIMALS; ANTICOAGULANTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; DIURETICS; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HALF-LIFE; KIDNEY; MALE; METABOLIC CLEARANCE RATE; PROTEIN BINDING; RABBITS; SERUM ALBUMIN; WARFARIN;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033008065     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Akcicek F, Yalniz T, Basci A, Ok E and Mees EJ (1995) Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? Br Med J 310:162-163.
2. Andreasen F and Mikkelsen E (1977) Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol 12:15-22.
3. Besseghir K, Mosig D and Roch-Ramel F (1989) Facilitation by serum albumin of renal tubular secretion of organic anions. Am J Physiol 256:F475-F484.
4. Chan E, McLachlan AJ, Pegg M, MacKay AD, Cole RB and Rowland M (1994) Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin. Br J Clin Pharmacol 37:563-569.
5. Depner TA, SanakaT and Stanfel LA (1984) Suppression of para-aminohippurate transport in the isolated perfused kidney by an inhibitor of protein binding in uremia. Am J Kidney Dis 3:280-286.
6. Ganeval D. Fischer AM, Barre J. Pertuiset N. Dautzenberg MD, Jungers P and Houin G (1985) Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors. Clin Nephrol 25:75-80.
7. Gibaldi M and Perner D (1982) Noncompartmental analysis based on statistical moment theory, in Pharmacokinetics (Swarbrick, J ed) pp 409-417, Marcel Dekker, New York.
8. Grantham JJ and Chonko AM (1993) Renal handling of organic anions, and cations; excretion of uric acid, in The Kidney (Brenner BM and Rector FC) pp 483-509, W B Saunders Company, Philadelphia.
9. Hammarlund-Udenaes M and Benet LZ (1989) Furosemide pharmacokinetics and pharmacodynamics in health and disease - an update. J Pharmacokinet Biopharm 17:1-46.
10. Homsy W. Marteau S and du Souich P (1995) Furosemide dynamics in conscious rabbits: modulation by angiotensin II. Cardiovasc Drugs Ther 9:311-317.
11. Inoue M, Koyama H, Nagase S and Morino Y (1985) Renal secretion of phenosulfonphthalein: analysis of its vectorial transport in normal and mutant analbuminemic rats. J Lab Clin Med 105:484-488.
12. Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S and Morino Y (1987) Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int 32:198-203.
13. Kirchner KA, Voelker JR and Brater DC (1991) Binding inhibitors restore furosemide potency in tubule fluid containing albumin. Kidney Int 40:418-424.
14. Lambert C, Caillé G and du Souich P (1982) Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat. J Pharmacol Exp Ther 222:232-236.
15. Okajima K, Inoue M, Itoh K, Nagase S and Morino Y (1985) Role of plasma albumin in renal elimination of a mercapturic acid. Analyses in normal and mutant analbuminemic rats. Eur J Biochem 150:195-199.
16. Pichette V and du Souich P (1996) Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid. J Am Soc Nephrol 7:345-349.
17. Pichelte V, Geadah D and du Souich P (1996) The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit. Br J Pharmacol 119:885-890.
18. Ponto LL and Schoenwald RD (1990a) Furosemide (frusemide): a pharmacokinetic/ pharmacodynamic review (Part I). Clin Pharmacokinet 18:381-408.
19. Ponto LL and Schoenwald RD (1990b) Furosemide (frusemide): a pharmacokinetic/ pharmacodynamic review (Part II). Clin Pharmacokinet 18:460-471.
20. Salive ME. Cornoni-Huntley J. Phillips CL, Guralnik JM, Cohen HJ, Ostfeld AM and Wallace RB (1992) Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol 45:213-221.
21. 3H morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney. J Pharmacol Exp Ther 223:811-815.
22. Schreiner GE (1950) Determination of inulin by means of resorcinol (17827). Proc Soc Exp Bio Med 74:117-120.
23. Shetty HG, Fennerty AG and Routledge PA (1989) Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy. Clin Pharmacokinet 16:238-253.
24. Sjoholm I, Ekman B, Kober A, Ljungstedt-Pahlman I, Seiving B and Sjodin T (1979) Binding of drugs to human serum albumin: XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. Mol Pharmacol 16:767-777
25. Sjostrom PA, Odlind BG, Beermann BA and Karlberg BE (1989) Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome. Eur J Clin Pharmacol 37:173-180.
26. Tongia SK (1981) Antagonism of frusemide diuresis by diphenylhydantoin sodium. Indian J Med Res 74:572-574.